These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2679028)

  • 41. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
    McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
    Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy.
    Grundy SM
    Am J Cardiol; 1995 Feb; 75(6):45B-52B. PubMed ID: 7863974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of risk factors in men with premature coronary artery disease.
    Genest JJ; McNamara JR; Salem DN; Schaefer EJ
    Am J Cardiol; 1991 Jun; 67(15):1185-9. PubMed ID: 2035438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection and treatment of elevated blood lipids and other risk factors for coronary artery disease in youth.
    Kwiterovich PO
    Ann N Y Acad Sci; 1995 Jan; 748():313-30; discussion 331-2. PubMed ID: 7695175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of dyslipidemia in non-insulin-dependent diabetes mellitus with lovastatin.
    Garg A; Grundy SM
    Am J Cardiol; 1988 Nov; 62(15):44J-49J. PubMed ID: 3055923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Achieving National Cholesterol Education Program goals in coronary artery disease.
    Rondina MT; Zebrack JS
    Prev Cardiol; 2005; 8(1):18-22. PubMed ID: 15722690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Women, lipoproteins and cardiovascular disease risk.
    LaRosa JC
    Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
    Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
    Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.
    Allison TG; Squires RW; Johnson BD; Gau GT
    Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B.
    Stein EA; Sniderman A; Laskarzewski P
    Am J Cardiol; 2005 Nov; 96(9A):36K-43K; discussion 34K-35K. PubMed ID: 16291013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases.
    Nakajima K; Nakajima Y; Takeichi S; Fujita MQ
    Atherosclerosis; 2008 May; 198(1):237-46. PubMed ID: 17977545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology of atherosclerosis: an updated overview.
    Criqui MH
    Am J Cardiol; 1986 Feb; 57(5):18C-23C. PubMed ID: 3511663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma lipid and lipoprotein concentrations in Chinese males with coronary artery disease, with and without hypertension.
    Shieh SM; Shen M; Fuh MM; Chen YD; Reaven GM
    Atherosclerosis; 1987 Sep; 67(1):49-55. PubMed ID: 3675705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and identification of abnormal lipoprotein levels in a biracial population aged 23 to 35 years (the CARDIA Study). The Coronary Artery Risk Development in Young Adults Study.
    Gidding SS; Liu K; Bild DE; Flack J; Gardin J; Ruth KJ; Oberman A
    Am J Cardiol; 1996 Aug; 78(3):304-8. PubMed ID: 8759809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.